Improving the Evidence Base for Delivery of High-Quality Cancer Care

Zaina P Qureshi^{1

2

3}, Patricia A Ganz^{4

5}, Charles L Bennett^{1

2

3

6}

Affiliations

¹ Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia.
² The Southern Network on Adverse Reaction (SONAR) Project, the South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia.
³ WJB Dorn VA Medical Center, Columbia, South Carolina.
⁴ Jonsson Comprehensive Cancer Center, University of California, Los Angeles.
⁵ Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California.
⁶ Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.

Comment

Zaina P Qureshi et al. JAMA Oncol. 2017.

. 2017 Aug 1;3(8):1029-1031.

doi: 10.1001/jamaoncol.2016.6722.

Zaina P Qureshi^{1

2

3}, Patricia A Ganz^{4

5}, Charles L Bennett^{1

2

3

6}

¹ Department of Health Services Policy and Management, Arnold School of Public Health, University of South Carolina, Columbia.
² The Southern Network on Adverse Reaction (SONAR) Project, the South Carolina Center of Economic Excellence for Medication Safety, College of Pharmacy, University of South Carolina, Columbia.
³ WJB Dorn VA Medical Center, Columbia, South Carolina.
⁴ Jonsson Comprehensive Cancer Center, University of California, Los Angeles.
⁵ Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angeles, California.
⁶ Hollings Cancer Center, Medical University of South Carolina, Charleston, South Carolina.

No abstract available

Comment on

Feasibility Assessment of Patient Reporting of Symptomatic Adverse Events in Multicenter Cancer Clinical Trials.
Basch E, Dueck AC, Rogak LJ, Minasian LM, Kelly WK, O'Mara AM, Denicoff AM, Seisler D, Atherton PJ, Paskett E, Carey L, Dickler M, Heist RS, Himelstein A, Rugo HS, Sikov WM, Socinski MA, Venook AP, Weckstein DJ, Lake DE, Biggs DD, Freedman RA, Kuzma C, Kirshner JJ, Schrag D. Basch E, et al. JAMA Oncol. 2017 Aug 1;3(8):1043-1050. doi: 10.1001/jamaoncol.2016.6749. JAMA Oncol. 2017. PMID: 28208174 Free PMC article. Clinical Trial.

Patient Report of Recurrent and Persistent Thyroid Cancer.
Papaleontiou M, Evron JM, Esfandiari NH, Reyes-Gastelum D, Ward KC, Hamilton AS, Worden F, Haymart MR. Papaleontiou M, et al. Thyroid. 2020 Sep;30(9):1297-1305. doi: 10.1089/thy.2019.0652. Epub 2020 Apr 16. Thyroid. 2020. PMID: 32183609 Free PMC article.
Comparison of self-reported and register-based hospital medical data on comorbidities in women.
Ho PJ, Tan CS, Shawon SR, Eriksson M, Lim LY, Miao H, Png E, Chia KS, Hartman M, Ludvigsson JF, Czene K, Hall P, Li J. Ho PJ, et al. Sci Rep. 2019 Mar 5;9(1):3527. doi: 10.1038/s41598-019-40072-0. Sci Rep. 2019. PMID: 30837593 Free PMC article.